Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Quinine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/09/2021 2 0
Pyronaridine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 3 0
Ebselen Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 3 2
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Desethylamodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/08/2020 1 0
Ferroquine Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020 1 0
Excel (.xslx) CSV (.csv)